The World Health Organization on Monday authorized the use of the AstraZeneca-Oxford vaccine, clearing a path for the cheap and easy-to-store shots to be distributed in lower- and middle-income countries around the world.

A small clinical trial in South Africa recently failed to show that the vaccine could keep people from getting mild or moderate cases of Covid-19 caused by a coronavirus variant spreading there. But that vaccine had protected all participants against severe disease and death in other trials and may yet prevent severe disease and death caused by the variant first detected in South Africa.

The authorization, expected after a panel of W.H.O. experts recommended use of the vaccine last week, applied to the vaccine’s two manufacturers: AstraZeneca and the Serum Institute, the Indian producer that will supply many doses for the Covax initiative to bring vaccines to poorer parts of the world.

The W.H.O. last year authorized Pfizer-BioNTech vaccine. But its decision on AstraZeneca’s vaccine has been highly anticipated because the low price and easy storage requirements have made the vaccine the backbone of rollout plans in many countries around the world.

“Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the Covax Facility’s goal of equitable vaccine distribution,” Dr. Mariângela Simão, the W.H.O. assistant-director general for access to medicines and health products, said in a statement.

The W.H.O. panel of experts recommended that the AstraZeneca vaccine be used in all adults, and in countries where concerning new variants are circulating. Countries are expected to begin receiving their first tranches of the AstraZeneca vaccine from Covax later in February.

In announcing the authorization for the vaccine on Monday, Dr. Tedros Adhanom Ghebreyesus, the director-general of the W.H.O., said that while virus cases appeared to be falling in many parts of the world, countries needed to remain vigilant. “If we stop fighting it on any front,” he said, “it will come roaring back.”

Todd Horwitz Chief Strategist BubbaTrading.com
Stop being a prophet and make profits


Last Saturday we presented for our Hedging Model for the next class. Below is the link for the recording.

Webinar Recording Hedging your Portfolio Saturday

We have also included a registration link for session 6 of our Options Trading education on Friday February 19th at 5:00 EST

2021-02-19 Options Training Session 6 Register here